Key result
Integrating advanced cardiac imaging and genetic testing enhances diagnostic accuracy and risk stratification in cardiomyopathies.
Why the study?
Recent advances in non-invasive imaging and genetic testing have transformed diagnostic accuracy and risk stratification, prompting a summary of their current state and future perspectives in cardiomyopathies.
Advanced cardiac imaging and genetic testing synergistically improve the diagnosis, risk stratification, and personalized management of cardiomyopathies.
No takes yet. Share an insight, caveat, or question.
Supports combined imaging-genetic evaluation in cardiomyopathies; leaves open prospective validation before practice change.
Tomasz Gąsior (2024) conducted a review in Cardiomyopathies. Cardiac imaging and genetic testing was evaluated. Integrating advanced cardiac imaging and genetic testing enhances diagnostic accuracy, risk stratification, and personalized management for patients with cardiomyopathies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: